Relmada Therapeutics Inc (RLMD)
3.68
-0.04
(-1.08%)
USD |
NASDAQ |
May 03, 16:00
3.66
-0.02
(-0.54%)
After-Hours: 20:00
Relmada Therapeutics Shares Outstanding: 30.17M for March 27, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 27, 2024 | 30.17M |
March 15, 2024 | 30.17M |
December 31, 2023 | 30.10M |
November 06, 2023 | 30.10M |
September 30, 2023 | 30.10M |
August 03, 2023 | 30.10M |
June 30, 2023 | 30.10M |
June 12, 2023 | 30.10M |
May 09, 2023 | 30.10M |
March 31, 2023 | 30.10M |
March 28, 2023 | 30.10M |
March 20, 2023 | 30.10M |
December 31, 2022 | 30.10M |
November 07, 2022 | 30.10M |
September 30, 2022 | 28.64M |
September 22, 2022 | 28.61M |
August 09, 2022 | 30.06M |
June 30, 2022 | 30.02M |
May 02, 2022 | 29.99M |
April 06, 2022 | 29.43M |
March 31, 2022 | 29.40M |
March 28, 2022 | 29.37M |
March 21, 2022 | 29.37M |
December 31, 2021 | 27.74M |
December 13, 2021 | 27.73M |
Date | Value |
---|---|
December 07, 2021 | 17.58M |
November 10, 2021 | 17.53M |
September 30, 2021 | 17.50M |
August 06, 2021 | 17.47M |
June 30, 2021 | 17.47M |
June 03, 2021 | 17.47M |
May 07, 2021 | 16.80M |
March 31, 2021 | 16.75M |
March 22, 2021 | 16.75M |
March 15, 2021 | 16.75M |
December 31, 2020 | 16.33M |
November 09, 2020 | 16.24M |
September 30, 2020 | 16.19M |
August 05, 2020 | 16.02M |
June 30, 2020 | 15.85M |
May 13, 2020 | 15.20M |
March 31, 2020 | 14.94M |
March 26, 2020 | 14.94M |
March 11, 2020 | 14.89M |
January 30, 2020 | 14.67M |
January 15, 2020 | 14.54M |
December 31, 2019 | 14.46M |
December 06, 2019 | 14.22M |
December 02, 2019 | 10.38M |
November 08, 2019 | 10.28M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
8.314M
Minimum
May 14 2019
30.17M
Maximum
Mar 15 2024
20.69M
Average
17.47M
Median
Jun 30 2021
Shares Outstanding Benchmarks
Cyclacel Pharmaceuticals Inc | 1.318M |
Lifecore Biomedical Inc | 30.55M |
Harrow Inc | 35.36M |
Corvus Pharmaceuticals Inc | 49.04M |
Aquestive Therapeutics Inc | 73.30M |